Cook Regentec has announced the first clinical use in the USA of the Advance CS coronary sinus infusion catheter and CompassCT disposable pressure transducer to deliver a therapeutic in heart failure patients. The Advance CS coronary sinus infusion catheter is a percutaneous balloon infusion catheter designed for use in retrograde coronary sinus infusion procedures.
A press release reports that the catheter is used to infuse therapeutic agents into the heart via the coronary venous system. It adds that the Compass CT disposable pressure transducer provides continuous monitoring of infusion pressure and pressure in the patient’s heart during the procedure. The Advance CS coronary sinus infusion catheter is intended for temporary occlusion of the coronary sinus for infusion of contrast media, drugs, and therapeutic agents, or possible introduction of devices into the coronary venous system.
Amit N Patel (University of Miami Health System, Miami, USA), says: “Using the Advance CS coronary sinus infusion catheter, clinicians can deliver therapeutics, including cell and gene therapies, in an out-patient setting. What we once performed on patients through invasive surgery can now be done in a minimally invasive procedure, lowering medical costs, increasing patient safety and delivering the most effective biologics to treat each patient. In the evolution of gene and cell therapies, this is a revolutionary medical device for both clinicians and patients.”
The Compass CT disposable pressure transducer—a disposable pressure transducer featuring an integrated digital display—monitors physiological pressure and displays pressure during the infusion of therapeutic agents.